Slynd now with Special Container status

From 1 June 2024, Drospirenone (Slynd) 4mg tablets were re-classified as a special container at sub-pack level (sub-pack of 28)

This means that reimbursement will be for the nearest complete sub-pack to the quantity ordered.

Community Pharmacy England believes nearly 900 products that appear to meet one or more of the special container criteria are not annotated as such in the Drug Tariffand/or the NHS Dictionary of Medicines and Devices (dm+d).

Dispensary guidance news England Wales

Latest news

DDA raises rural GP issues in Westminster event

DDA Board Member Dr Ian Hume raised the rural challenges facing dispensing GPs in a Rebuild General Practice campaign roundtable with Liberal Democrat MPs.The discussion focused on the challenges facing GP practices across the country, from rising de

MSN: lansoprazole 15mg and 30mg orodispersible tablets

DHSC has published a Tier 2 Medicine Supply Notification (MSN) for lansoprazole 15mg and 30mg orodispersible tablets: limited supply until early January 2027. Up-to-date information abour medicine supply issues can be found in the DHSC and NHSE

England & Wales: August price redetermination

The Department of Health and Social Care has confirmed that the reimbursement price for the following products in the table have been redetermined. This is to reflect an increase in the NHS list price. Generic name Brand name Pack size Ne

Slynd now with Special Container status

Latest news

DDA raises rural GP issues in Westminster event

MSN: lansoprazole 15mg and 30mg orodispersible tablets

England & Wales: August price redetermination

View all news

DDA Suppliers Directory

MediP

Dispensing Doctor Experts

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association